Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action.

Dean O, Giorlando F, Berk M.

J Psychiatry Neurosci. 2011 Mar;36(2):78-86. doi: 10.1503/jpn.100057. Review.

PMID:
21118657
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

The promise of N-acetylcysteine in neuropsychiatry.

Berk M, Malhi GS, Gray LJ, Dean OM.

Trends Pharmacol Sci. 2013 Mar;34(3):167-77. doi: 10.1016/j.tips.2013.01.001. Epub 2013 Jan 29. Review.

PMID:
23369637
[PubMed - indexed for MEDLINE]
3.

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility.

Dodd S, Dean O, Copolov DL, Malhi GS, Berk M.

Expert Opin Biol Ther. 2008 Dec;8(12):1955-62. doi: 10.1517/14728220802517901 . Review.

PMID:
18990082
[PubMed - indexed for MEDLINE]
4.

Minocycline: therapeutic potential in psychiatry.

Dean OM, Data-Franco J, Giorlando F, Berk M.

CNS Drugs. 2012 May 1;26(5):391-401. doi: 10.2165/11632000-000000000-00000. Review.

PMID:
22486246
[PubMed - indexed for MEDLINE]
5.

Glutathione: a novel treatment target in psychiatry.

Berk M, Ng F, Dean O, Dodd S, Bush AI.

Trends Pharmacol Sci. 2008 Jul;29(7):346-51. doi: 10.1016/j.tips.2008.05.001. Epub 2008 Jun 4. Review.

PMID:
18538422
[PubMed - indexed for MEDLINE]
6.

Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review.

Sadowska AM, Manuel-Y-Keenoy B, De Backer WA.

Pulm Pharmacol Ther. 2007;20(1):9-22. Epub 2006 Feb 3. Review.

PMID:
16458553
[PubMed - indexed for MEDLINE]
7.

The chemistry and biological activities of N-acetylcysteine.

Samuni Y, Goldstein S, Dean OM, Berk M.

Biochim Biophys Acta. 2013 Aug;1830(8):4117-29. doi: 10.1016/j.bbagen.2013.04.016. Epub 2013 Apr 22. Review.

PMID:
23618697
[PubMed - indexed for MEDLINE]
Free Article
8.

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy.

Johannessen Landmark C.

CNS Drugs. 2008;22(1):27-47. Review.

PMID:
18072813
[PubMed - indexed for MEDLINE]
9.

Glutamatergic medications for the treatment of drug and behavioral addictions.

Olive MF, Cleva RM, Kalivas PW, Malcolm RJ.

Pharmacol Biochem Behav. 2012 Feb;100(4):801-10. doi: 10.1016/j.pbb.2011.04.015. Epub 2011 Apr 22. Review.

PMID:
21536062
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

N-acetylcysteine (NAC) and glutathione (GSH): antioxidant and chemopreventive properties, with special reference to lung cancer.

van Zandwijk N.

J Cell Biochem Suppl. 1995;22:24-32. Review.

PMID:
8538205
[PubMed - indexed for MEDLINE]
11.

[Alpha-interferon and mental disorders].

Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.

Encephale. 2001 Jul-Aug;27(4):308-17. Review. French.

PMID:
11686052
[PubMed - indexed for MEDLINE]
12.

A retrospective chart review of risperidone use in treatment-resistant children and adolescents with psychiatric disorders.

Simeon J, Milin R, Walker S.

Prog Neuropsychopharmacol Biol Psychiatry. 2002 Feb;26(2):267-75. Review.

PMID:
11817503
[PubMed - indexed for MEDLINE]
13.

Nutraceuticals in the treatment of obsessive compulsive disorder (OCD): a review of mechanistic and clinical evidence.

Camfield DA, Sarris J, Berk M.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jun 1;35(4):887-95. doi: 10.1016/j.pnpbp.2011.02.011. Epub 2011 Feb 23. Review.

PMID:
21352883
[PubMed - indexed for MEDLINE]
14.

[Diagnostic structured interviews in child and adolescent's psychiatry].

Renou S, Hergueta T, Flament M, Mouren-Simeoni MC, Lecrubier Y.

Encephale. 2004 Mar-Apr;30(2):122-34. Review. French.

PMID:
15107714
[PubMed - indexed for MEDLINE]
15.

Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.

Gillissen A, Nowak D.

Respir Med. 1998 Apr;92(4):609-23. Review.

PMID:
9659525
[PubMed - indexed for MEDLINE]
Free Article
16.

Clinical applications of N-acetylcysteine.

Kelly GS.

Altern Med Rev. 1998 Apr;3(2):114-27. Review.

PMID:
9577247
[PubMed - indexed for MEDLINE]
Free Article
17.

N-acetylcysteine and neurodegenerative diseases: basic and clinical pharmacology.

Arakawa M, Ito Y.

Cerebellum. 2007;6(4):308-14. doi: 10.1080/14734220601142878. Epub 2007 Jan 19. Review.

PMID:
17853088
[PubMed - indexed for MEDLINE]
18.

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications.

Ng F, Berk M, Dean O, Bush AI.

Int J Neuropsychopharmacol. 2008 Sep;11(6):851-76. doi: 10.1017/S1461145707008401. Epub 2008 Jan 21. Review.

PMID:
18205981
[PubMed - indexed for MEDLINE]
19.

Utility of acetylcysteine in treating poisonings and adverse drug reactions.

Chyka PA, Butler AY, Holliman BJ, Herman MI.

Drug Saf. 2000 Feb;22(2):123-48. Review.

PMID:
10672895
[PubMed - indexed for MEDLINE]
20.

Prevention of ifosfamide nephrotoxicity by N-acetylcysteine: clinical pharmacokinetic considerations.

Chen N, Aleksa K, Woodland C, Rieder M, Koren G.

Can J Clin Pharmacol. 2007 Summer;14(2):e246-50. Epub 2007 Jul 24. Review.

PMID:
17652768
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk